John Michael DiMaio
Known title: DirectorCIK: 0001993856
John Michael DiMaio's purchase track record
How the stock did after each of John Michael DiMaio's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since September 12, 2023
Stock higher 6 months later
0%
3 months: 0%
Median 6-month return
-38.6%
3 months: -24.4%
Beat the S&P 500
0%
median -55.3% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/10/2024 | MDAI | $10K | -11.7% | -21.1% | +14.8% |
| 11/14/2023 | MDAI | $8K | -24.4% | -38.6% | +16.7% |
| 9/12/2023 | MDAI | $7K | -48.9% | -64.3% | +16.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MDAI | ▲ Buy | Grant | 32,000 | $52K | 9/28/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 60,000 | $100K | 9/23/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 21,012 | $36K | 9/21/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 10,988 | $18K | 9/18/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 22,000 | $35K | 9/11/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 10,000 | $16K | 9/10/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 35,000 | $57K | 8/13/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 15,000 | $26K | 6/29/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 14,700 | $25K | 6/25/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 14,300 | $25K | 6/24/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 15,000 | $32K | 5/29/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 2,500 | $6K | 5/28/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 32,233 | $84K | 5/26/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 1,887 | $4K | 5/15/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 25,000 | $54K | 5/15/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 100,000 | $0 | 4/24/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 7,619 | $12K | 3/27/2026 | View on chart |
| MDAI | ▲ Buy | Grant | 9,700 | $20K | 6/10/2025 | View on chart |
| MDAI | ▲ Buy | Grant | 2,000 | $4K | 6/9/2025 | View on chart |
| MDAI | ▲ Buy | Open Market | 6,000 | $10K | 5/10/2024 | View on chart |
| MDAI | ▼ Sell | Other | 2,000 | $4K | 1/19/2024 | View on chart |
| MDAI | ▼ Sell | Other | 2,000 | $5K | 1/9/2024 | View on chart |
| MDAI | ▲ Buy | Open Market | 2,000 | $5K | 11/20/2023 | View on chart |
| MDAI | ▲ Buy | Open Market | 500 | $1K | 11/16/2023 | View on chart |
| MDAI | ▲ Buy | Open Market | 355 | $998 | 11/14/2023 | View on chart |
| MDAI | ▲ Buy | Open Market | 198 | $1K | 9/13/2023 | View on chart |
| MDAI | ▲ Buy | Open Market | 1,000 | $6K | 9/12/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Spectral AI to Present Burn Wound Imaging Data at ACS 2026
Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.
Spectral AI to Present Burn Wound Imaging Data at ACS 2026. Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.